Liven Pharma (KAR:LIVEN) EBITDA Margin %: 0.00% (As of . 20)


What is Liven Pharma EBITDA Margin %?

Liven Pharma KAR:LIVEN -1.33% EBITDA Margin % is 0.00% as of . 20. The stock has 1 warning sign investors should review. Among 1,039 Manufacturing - Apparel & Accessories companies, Liven Pharma ranks worse than 96246.29% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Liven Pharma's EBITDA for the six months ended in . 20 was ₨0.00 Mil. Liven Pharma's Revenue for the six months ended in . 20 was ₨0.00 Mil. Therefore, Liven Pharma's EBITDA margin for the quarter that ended in . 20 was 0.00%.

Liven Pharma  (KAR:LIVEN) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Liven Pharma EBITDA Margin % Related Terms

Liven Pharma EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Liven Pharma's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Liven Pharma EBITDA Margin % Chart

Liven Pharma Annual Data
Trend
EBITDA Margin %

Liven Pharma Semi-Annual Data
EBITDA Margin %

KAR:LIVEN vs AIN: EBITDA Margin % Comparison

For the Textile Manufacturing subindustry, Liven Pharma's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Liven Pharma EBITDA Margin % vs Manufacturing - Apparel & Accessories Industry

For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Liven Pharma's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Liven Pharma's EBITDA Margin % falls into.


Liven Pharma EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Liven Pharma's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (A: . 20 )/Revenue (A: . 20 )
=/
= %

Liven Pharma's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Liven Pharma (KAR:LIVEN) has a EBITDA Margin % of 0.00% as of . 20. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Liven Pharma and its competitors. According to the industry distribution chart, Liven Pharma ranks #999999 out of 1039 companies in the Manufacturing - Apparel & Accessories industry.
Is Liven Pharma's EBITDA Margin % too high?
Liven Pharma's current EBITDA Margin % is 0.00%. Based on the distribution chart, Liven Pharma ranks #999999 out of 1039 companies in the Manufacturing - Apparel & Accessories industry, which is in the bottom quartile relative to peers.
How does Liven Pharma's EBITDA Margin % compare to AIN?
According to the Manufacturing - Apparel & Accessories industry distribution chart, Liven Pharma ranks #999999 out of 1039 companies for EBITDA Margin %. This places Liven Pharma in the lower half of its industry. The industry median EBITDA Margin % is 8.42. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Manufacturing - Apparel & Accessories company?
The median EBITDA Margin % among Manufacturing - Apparel & Accessories companies is 8.42, based on 1,039 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Liven Pharma and its competitors. For the Manufacturing - Apparel & Accessories industry, the median EBITDA Margin % is 8.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Liven Pharma's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Liven Pharma stock overvalued right now?
Liven Pharma (KAR:LIVEN) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Liven Pharma (KAR:LIVEN), the current EBITDA Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Liven Pharma Business Description

Address I.I Chundrigar Road, 1st Floor, The Cotton Exchange Building, Karachi, SD, PAK, 75350
Liven Pharma Ltd, formerly Landmark Spinning Industries Ltd is engaged in trading, manufacturing, and sale of yarn.